Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers
Launched by INSTITUT DU CANCER DE MONTPELLIER - VAL D'AURELLE · Jun 5, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating a special database that collects important information about patients with certain types of cancer, specifically epithelial ovarian cancer, fallopian tube cancer, and primitive peritoneal cancer. The goal of this study is to gather blood and tissue samples along with clinical data to help researchers better understand these cancers and develop new treatments. This information will be shared with the scientific community to advance cancer research and improve patient care.
To participate in this study, you need to be at least 18 years old and have been diagnosed with one of the specified cancers. You should also be eligible for surgery and chemotherapy. Participants will need to provide their written consent to join the trial. It’s important to note that this study is currently recruiting patients of all genders, and those who are pregnant, nursing, or face certain legal or social constraints are not eligible to participate. If you choose to join, you will be contributing to a vital effort that could lead to improved treatments for these challenging cancers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 or older
- • Patient at the diagnosis of an epithelial ovarian cancer, or a fallopian tube caner or a primitive peritoneal cancer
- • Patient eligible for, at least, one surgery and a chemotherapy
- • Patient having given his informed, written and express consent
- Exclusion Criteria:
- • Patient not affiliated to a social protection scheme
- • Pregnant and / or nursing women
- • Subject under tutelage, curatorship or safeguard of justice
- • Patient whose regular follow-up is impossible for psychological, familial, social or geographical reasons
About Institut Du Cancer De Montpellier Val D'aurelle
The Institut du Cancer de Montpellier - Val d'Aurelle is a leading cancer research and treatment center located in Montpellier, France. Committed to advancing oncology through innovative clinical trials and research initiatives, the institute integrates cutting-edge scientific discovery with patient-centered care. With a multidisciplinary team of experts, it focuses on developing new therapeutic strategies and improving outcomes for cancer patients. The institute fosters collaboration with academic institutions and industry partners, aiming to translate research findings into effective clinical applications for a diverse range of cancers.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, , France
Patients applied
Trial Officials
COLOMBO Pierre-Emmanuel, M.D
Principal Investigator
ICM - Institut régional du Cancer Montpellier
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials